| Pravagen Claim To Improve
Memory Draws Lawsuit Getting Forgotten In SDNY
Until November
By Matthew
Russell Lee, Patreon
BBC
- Guardian
UK - Honduras
- The
Source
SDNY COURTHOUSE,
May 1 –
In
2019, James Venderwerff was
the named plaintiff in a
purported class action against
Quincy Bioscience Holding
Company, Inc. and others for
alleged fraud in connection
with Pravagen, a dietary
supplement that is claimed to
improve memory.
Now amid
Coronavirus, the case is on
the slow track. U.S. District
Court for the Southern
District of New York Judge
Ronnie Abrams held a
proceeding on May 1, which
Inner City Press covered.
Both
sides spoke of a mediation
elsewhere; ultimately the SDNY
case was put off until Friday,
November 13. Sometimes the
SDNY just gets used.
The case is Spath
v. Quincy Bioscience Holding
Company, Inc., et al.,
19-cv-7582
(Abrams).
***
Your
support means a lot. As little as $5 a month
helps keep us going and grants you access to
exclusive bonus material on our Patreon
page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2020 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com for
|
,
